Federica Saletta Selected Research

Federica Saletta Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 08/2006
5	Neuroblastoma 07/2021 - 11/2015
3	Hypoxia (Hypoxemia) 01/2013 - 03/2010
2	Iron Deficiencies 10/2011 - 03/2010
2	Chromosomal Instability (Chromosome Stability) 08/2007 - 08/2006
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2021
1	Prostatic Neoplasms (Prostate Cancer) 06/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Brain Diseases (Brain Disorder) 12/2020
1	Hepatoblastoma 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Friedreich Ataxia (Friedreich's Ataxia) 12/2012
1	Lung Neoplasms (Lung Cancer) 01/2009
1	Carcinoma (Carcinomatosis) 05/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2007
1	Carcinogenesis 05/2007
1	Xeroderma Pigmentosum (Kaposi's Disease) 08/2006

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2007
5	IronIBA 01/2013 - 03/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2006
3	Chelating AgentsIBA 01/2021 - 03/2010
3	CopperIBA 01/2021 - 01/2018
3	Messenger RNA (mRNA)IBA 10/2020 - 12/2010
2	Biological ProductsIBA 06/2021 - 03/2010
2	Dextrans (Dextran)FDA Link 06/2021 - 01/2018
2	Copper Transporter 1IBA 10/2020 - 01/2018
2	B7-H1 AntigenIBA 10/2020 - 11/2017
2	Codon (Codons)IBA 01/2009 - 08/2006
2	4-biphenylamineIBA 08/2007 - 05/2007
1	Circulating Tumor DNAIBA 07/2021
1	Cell-Free Nucleic AcidsIBA 07/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021
1	CurcuminIBA 06/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	AntigensIBA 01/2021
1	Erythropoietin FDA Link 01/2021
1	MetalsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	CateninsIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Death Domain ReceptorsIBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	CarbonIBA 04/2020
1	cupric chloride (copper(II) chloride)FDA Link 01/2018
1	Catechin (Z 7300)IBA 01/2018
1	Glutathione (Reduced Glutathione)IBA 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017
1	CBLC137IBA 11/2015
1	Histone ChaperonesIBA 11/2015
1	ChromatinIBA 11/2015
1	Vorinostat FDA Link 04/2014
1	tipifarnib (R115777)IBA 04/2014
1	Sorafenib (BAY 43-9006)FDA Link 04/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2014
1	Bortezomib (Velcade)FDA Link 04/2014
1	Bevacizumab (Avastin)FDA Link 04/2014
1	MTOR InhibitorsIBA 04/2014
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2013
1	TunicamycinIBA 01/2013
1	Eukaryotic Initiation Factor-3IBA 12/2010
1	Peptide Initiation Factors (Initiation Factor)IBA 12/2010
1	Transcription Factors (Transcription Factor)IBA 03/2010
1	Methylnitronitrosoguanidine (MNNG)IBA 08/2007
1	SmokeIBA 08/2007
1	AminesIBA 05/2007
1	DNA AdductsIBA 05/2007
1	CarcinogensIBA 08/2006

Therapy/Procedure

9	Therapeutics 01/2022 - 12/2011
2	Precision Medicine 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 11/2015 - 04/2014
1	Heterologous Transplantation (Xenotransplantation) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021